![Nicolás Kirchuk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicolás Kirchuk
Director Ejecutivo en Biomakers Molecular Pathology & Research .
Perfil
Nicolás Kirchuk is the founder of Biomakers Molecular Pathology & Research.
He held the title of Co-Chief Executive Officer at the company.
Cargos activos de Nicolás Kirchuk
Empresas | Cargo | Inicio |
---|---|---|
Biomakers Molecular Pathology & Research
![]() Biomakers Molecular Pathology & Research Pharmaceuticals: MajorHealth Technology Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Biomakers Molecular Pathology & Research
![]() Biomakers Molecular Pathology & Research Pharmaceuticals: MajorHealth Technology Biomakers Molecular Pathology & Research is a company based in Buenos Aires, Argentina that specializes in molecular testing and genetic diagnosis to provide personalized treatment for patients with cancer and rare diseases. The Argentinean company offers comprehensive testing programs and use artificial intelligence and predictive platforms to generate high-quality genomic information and develop deep scientific and bioinformatics analysis. Biomakers has a department of premium international logistics that guarantees the collection and transfer of biological samples to their laboratories with the best traceability and times at the regional level. The company also has strategic partnership agreements with world-leading drug companies for cancer and rare diseases. The company was founded by Nicolás Kirchuk and Rubén Salanova, and Nicolás Kirchuk has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Nicolás Kirchuk